135 filings
Page 4 of 7
PREC14A
tj778
30 Mar 22
Preliminary proxy with contested solicitation
5:23pm
DEFA14A
zsze8qo6
30 Mar 22
Additional proxy soliciting materials
4:00pm
DFAN14A
s5yvm197wrzrn77t
30 Mar 22
Additional proxy materials by non-management
10:21am
DEFA14A
u2e986j3 jxbkwt6zdi
28 Mar 22
Additional proxy soliciting materials
5:31pm
S-8
ocoo4fu05 kzwp43pd1w
28 Mar 22
Registration of securities for employees
5:13pm
PREC14A
622z2k0
25 Mar 22
Preliminary proxy with contested solicitation
5:15pm
CORRESP
s7pfu eokevm5m3pw5e6
25 Mar 22
Correspondence with SEC
12:00am
8-K
bxzgve7vn
24 Mar 22
Athira Pharma Reports Full Year 2021 Financial Results and Provides Clinical Update
4:11pm
8-K
ay0xr7tgeun qvbwzm7
21 Mar 22
Athira Pharma Announces Appointment of Dr. Michael A. Panzara to its Board of Directors
7:21am
8-K
zstic
31 Jan 22
Athira Pharma Announces Appointment of Grant Pickering to its Board of Directors
4:15pm
EFFECT
mz4qj85ydb
26 Nov 21
Notice of effectiveness
12:15am
UPLOAD
gfi4j6
22 Nov 21
Letter from SEC
12:00am
CORRESP
juw5xb 9dvhv
22 Nov 21
Correspondence with SEC
12:00am
S-3
jdtgyr
15 Nov 21
Shelf registration
4:06pm
8-K
9fwvf
10 Nov 21
Athira Pharma Reports Third Quarter 2021 Financial Results and Business Update
4:11pm
8-K
h23izwukdc 3a
21 Oct 21
Departure of Directors or Certain Officers
4:09pm
8-K
ys910gz4ei8kf8v ijf
16 Aug 21
Athira Pharma Reports Second Quarter 2021 Financial Results and Business Update
4:11pm